NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Vaccine Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Burkholderia



Studies from S.P. Sivalingam and co-researchers yield new data on Burkholderia



April 16th, 2008

According to a study from Singapore, Singapore, "Melioidosis, a potentially fatal disease of humans and animals, is caused by the Gram-negative bacterium, Burkholderia pseudomallei. There is no approved vaccine or effective prophylaxis."

"Given its potential as a bioterrorism agent and a cause of serious laboratory-acquired infection, we studied the efficacy of pre- and post-exposure oral antibiotic prophylaxis in BALB/c mice infected with aerosolized B. pseudomallei through the inhalational route. Amoxicillin/clavulanic acid, doxycycline or co-trimoxazole was administered 48 h before infection as pre- exposure prophylaxis, orally, twice daily and continued up to 10...


Source: Vaccine Weekly (2008-04-16)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login